MAVERDIANE
The computed 12-month bankruptcy probability of MAVERDIANE is 5.1% (elevated). The 2024 annual accounts show equity of €1k and a net result of €-1k. Equity is shrinking by ~22.6% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2027. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1k |
| Net result | €-1k |
| Active | 4 yrs |
| Locations | 1 |
Mixed profile: strong on solvency, weaker on profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-741 |
| Net profit | €-1k |
| Cash flow | €-845 |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €2k |
| Equity | €1k |
| Debt | €271 |
| of which ≤ 1y | - |
| of which > 1y | - |
| Working capital | - |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | - |
| Quick ratio | - |
| Working capital ratio | - |
| Solvency | 83.2% |
| Debt / equity | 0.20 |
| Long-term debt ratio | - |
| Interest coverage | -7.10 |
| Gross margin | - |
| Net margin | - |
| ROA | -71.0% |
| ROE | -85.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2k |
| Formation expenses | 20 | €603 |
| Current assets | 29/58 | €1k |
| Cash & bank | 54/58 | €1k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2k |
| Equity | 10/15 | €1k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €-2k |
| Amounts payable | 17/49 | €271 |
| Income statement | ||
| Gross operating margin | 9900 | €-550 |
| Operating result | 9901 | €-1k |
| Financial charges | 65 | €104 |
| Result before taxes | 9903 | €-1k |
| Net result for the period | 9904 | €-1k |
| Result to be appropriated | 9905 | €-1k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 13-01-2022 |
| Status | Active |
| Postal code | 4800 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63079D0418/00B006 | Wallonia | 3.5 ha | 1 · 484 m² | 11.5 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
04-02-2025 1 director appointed, 1 resigning
- Guillaume RESIMONT, Bestuurder
- Marie-Christine PAROTTE, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Guillaume RESIMONT",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-11-19",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de d\u00E9signer Guillaume RESIMONT en qualit\u00E9 Administrateur. Le mandat commence le 19/11/2024, pour une dur\u00E9e ind\u00E9termin\u00E9e.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Marie-Christine PAROTTE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-11-19",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale confirme la d\u00E9mission de Marie-Christine PAROTTE en qualit\u00E9 Administrateur. La d\u00E9mission prend effet le 19/11/2024.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-02-04",
"filing_date": "2025-01-17",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-11-19",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0780.432.108",
"name_full": "MAVERDIANE",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "DENYS BENNAng",
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | MAVERDIANE |